Home Tags Citius

Tag: citius

@NCI
CoronaVirus

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in...

Editor / Curator -
Citius, Biotech Stock Review
2020 Watch List

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

Editor / Curator -
Biotech News

Where is Citius Pharma (CTXR) in the FDA Approval Process?

Editor / Curator -
Citius Pharma
2020 Watch List

Citius Pharma (CTXR) On The Move.

Editor / Curator -
Superbug News - CoronaVirus Watch List

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and...

Editor / Curator -
Citius, Biotech Stock Review
Biotech News

Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal...

Editor / Curator -
steven boyd, biotech stock review
Biotech News

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

Editor / Curator -
candida auris, citius pharma, biotech stock review
Biotech News

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

Editor / Curator -

Latest article

Party Time at uniQure (QURE). $48 up 443%

Uncategorized Editor / Curator -
No Bells, no Baskets. But Still not out of the Woods!

We’re Up 360% in Six Weeks. Replimune (REPL).

2026 Biotech 12 Pack Editor / Curator -
That's a Gain of $604 Million, and That Ain't Bad! Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...

GeoVax (GOVX) Conference Call and Transcript.

2026 Biotech 12 Pack Editor / Curator -
Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? We have no...